MENU
OMGAQ
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Omega Therapeutics (OMGAQ) Ownership - Who owns Omega Therapeutics?
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.05M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.15 USD as % of share price
Fundamentals
OMGAQ
Capitalization
2.05M
P/E Ratio
N/A
Risk (Beta)
-0.16
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.15%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
0.18
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
1.28M
Shares Outstanding - Current
55.4M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-95.038
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information